IMMUNOHISTOCHEMICAL REACTIVITY IN MESOTHELIOMA AND ADENOCARCINOMA - A STEPWISE LOGISTIC-REGRESSION ANALYSIS

被引:36
作者
DEJMEK, A
HJERPE, A
机构
[1] HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT PATHOL 2,S-14186 HUDDINGE,SWEDEN
[2] LUND UNIV,MALMO GEN HOSP,DEPT CLIN CYTOL & PATHOL,S-21401 MALMO,SWEDEN
关键词
MESOTHELIOMA; DIAGNOSIS; IMMUNOHISTOCHEMISTRY; STEPWISE LOGISTIC REGRESSION ANALYSIS;
D O I
10.1111/j.1699-0463.1994.tb04873.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Histological sections from 103 malignant mesotheliomas and 43 adenocarcinoma metastases in pleural biopsies were investigated for reactivity against a panel of 11 different antibodies. The size of the material allowed the evaluation by stepwise logistic regression analysis, which selected five parameters of major importance: vimentin reactivity in epithelial cells, reactivity to low-molecular-weight keratins in fibrous cells, strong membrane accentuation of EMA reactivity, and lack of reactivity to LeuM1 and BerEp4. Three of these criteria were sufficient to identify a mesothelioma with high specificity and with a sensitivity of approximately 70%. Whilst the monoclonal anti-CEA tested was the most valuable single parameter, it did not add any diagnostic information to the combination of criteria selected by the stepwise logistic regression analysis. However, this antibody can be used to exclude most of the adenocarcinomas from further analysis with the more extensive panel.
引用
收藏
页码:255 / 264
页数:10
相关论文
共 39 条
[1]   DIFFUSE MALIGNANT MESOTHELIOMA OF PLEURA - DIAGNOSTIC-CRITERIA BASED ON AN AUTOPSY STUDY [J].
ADAMS, VI ;
UNNI, KK .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1984, 82 (01) :15-23
[3]  
BATTIFORA H, 1985, CANCER, V55, P1679, DOI 10.1002/1097-0142(19850415)55:8<1679::AID-CNCR2820550812>3.0.CO
[4]  
2-C
[5]  
BLOBEL GA, 1985, AM J PATHOL, V121, P235
[6]   REACTIVE AND NEOPLASTIC SEROSAL TISSUE - A LIGHT-MICROSCOPIC, ULTRASTRUCTURAL, AND IMMUNOCYTOCHEMICAL STUDY [J].
BOLEN, JW ;
HAMMAR, SP ;
MCNUTT, MA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1986, 10 (01) :34-47
[7]   MULTIPLE-MARKER IMMUNOHISTOCHEMICAL PHENOTYPES DISTINGUISHING MALIGNANT PLEURAL MESOTHELIOMA FROM PULMONARY ADENOCARCINOMA [J].
BROWN, RW ;
CLARK, GM ;
TANDON, AK ;
ALLRED, DC .
HUMAN PATHOLOGY, 1993, 24 (04) :347-354
[8]   DIFFUSE EPITHELIAL MESOTHELIOMA - A REVIEW OF THE ULTRASTRUCTURAL SPECTRUM [J].
DARDICK, I ;
JABI, M ;
MCCAUGHEY, WTE ;
DEODHARE, S ;
VANNOSTRAND, AWP ;
SRIGLEY, JR .
ULTRASTRUCTURAL PATHOLOGY, 1987, 11 (5-6) :503-533
[9]  
DEJMEK A, 1992, ANAL QUANT CYTOL, V14, P217
[10]  
DEJMEK A, 1994, CANCER, V73, P464, DOI 10.1002/1097-0142(19940115)73:2<464::AID-CNCR2820730235>3.0.CO